|
Tuesday, March 1 — 8:00 AM — Convention Center Room 203
Click on the numbers in parentheses to display abstracts.
Section H1 - PATHOBIOLOGY
Chaired by: Stephen Peiper and Brian P. Rubin
| 8:00 |
Pharmacodynamic Assessment of the Cyclin-Dependent Kinase Inhibitor Flavopiridol: Modulation of cdk Targets in Clinical Samples
(1375)
D Di Vizio, FP O'Connell, N Bhattacharya, GI Shapiro, M Loda - Dana Farber Cancer Institute; Brigham and Women's Hospital, Boston, MA
|
| 8:15 |
Role of p53, IGFR and EGFR in Clusterin Expression in Rectal Cancers
(1395)
J Willis, A Das, A Chak, K Ferguson, L Mayo, D Dawson, D Boothman - University Hospitals of Cleveland; Case Western Reserve University; Cleveland, Ohio
|
| 8:30 |
DNA Methylation Regulates Galectin-3 Expression in Various Cell Lines and in Pituitary Tumors
(1391)
KH Ruebel, L Jin, BW Scheithauer, K Kovacs, RV Lloyd - Mayo Clinic, Rochester, MN; St. Michaels Hospital, Toronto, ON, Canada
|
| 8:45 |
Intra-Tumor Depletion of CD4+ Cells Unmasks Tumor Immunogenicity Leading to Rejection of Established Tumor
(1384)
W Liu, P Yu, Y Lee, T Krausz, W Recant, Y Fu - The University of Chicago Hospitals, Chicago, IL
|
| 9:00 |
EBV Infection of NOD/SCID Mice Reconstituted with Human Hematopoitic CD34+ Cells: A Potential In Vivo Model for EBV Induced Lymphoproliferative Disorder (LPD) in Immunodeficient Patients
(1387)
GJ Netto, M Islas-Ohlmayer, R Domiati-Saad, A Padgett-Thomas, MW Melkus, PD Cravens, MP Martin, RS Scott, JW Sixbey, JV Garcia - Baylor University Medical Centre, Dallas, TX; University of Texas Southwestern Medical Centre, Dallas, TX; Louisiana State University Health Sciences Center, Shreveport, LA
|
| 9:15 |
A Mouse Model of Gastroinstestinal Stromal Tumor
(1390)
BP Rubin, ML Comstock, JP Scott-Browne, MR Tanas - University of Washington Medical Center, Seattle, WA
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
|
|
|
